PHARMING GRP SP. ADRS (PHG) — Capital Reinvestment Ratio
Latest as of December 2025:
0.03x
PHARMING GRP SP. ADRS (PHG) has a Capital Reinvestment Ratio of 0.03x as of December 2025, meaning it reinvests 0% of its operating cash flow (€10.71 Million) in capital expenditures (€269.00K). See PHARMING GRP SP. ADRS (PHG) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.03x
Capex / Operating Cash Flow
Operating Cash Flow
€10.71 Million
EUR
Capital Expenditures
€269.00K
EUR
Data as of
Dec 2025
Most recent filing
PHARMING GRP SP. ADRS Capital Reinvestment Ratio (2021–2025)
This chart tracks PHARMING GRP SP. ADRS's Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for PHARMING GRP SP. ADRS (2021–2025)
Year-by-year Capital Reinvestment Ratio for PHARMING GRP SP. ADRS from 2021 to 2025. For live market cap and broader valuation context, see PHG market cap overview.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.01x | €54.71 Million | €755.00K | ▼ -84.3% |
| 2022 | 0.09x | €22.46 Million | €1.98 Million | ▼ -80.1% |
| 2021 | 0.44x | €37.84 Million | €16.72 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow